David R. Walt Ph.D.
Net Worth
Last updated:
What is David R. Walt Ph.D. net worth?
The estimated net worth of Dr. David R. Walt Ph.D. is at least $7,764,859 as of 20 Aug 2024. He owns shares worth $7,436,859 as insider and has received compensation worth at least $328,000 in Quanterix Corporation.
What is the salary of David R. Walt Ph.D.?
Dr. David R. Walt Ph.D. salary is $41,000 per year as Co-Founder, Chairman of Scientific Advisory Board & Independent Director in Quanterix Corporation.
How old is David R. Walt Ph.D.?
Dr. David R. Walt Ph.D. is 72 years old, born in 1953.
What stocks does David R. Walt Ph.D. currently own?
As insider, Dr. David R. Walt Ph.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Quanterix Corporation (QTRX) | Co-Founder, Chairman of Scientific Advisory Board & Independent Director | 1,487,342 | $5 | $7,436,859 |
What does Quanterix Corporation do?
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
David R. Walt Ph.D. insider trading
Quanterix key executives
Quanterix Corporation executives and other stock owners filed with the SEC:
- Dr. David R. Walt Ph.D. (72) Co-Founder, Chairman of Scientific Advisory Board & Independent Director
- Mr. E. Kevin Hrusovsky (63) Chairman & Chief Executive Officer